vimarsana.com

Latest Breaking News On - Pfizer news - Page 3 : vimarsana.com

European Commission Approves Pfizer s PREVENAR 20® to Help Protect Infants and Children Against Pneumococcal Disease -March 13, 2024 at 04:03 am EDT

European Commission Approves Pfizer s PREVENAR 20® to Help Protect Infants and Children Against Pneumococcal Disease | Nation/World

European Commission Approves Pfizer s PREVENAR 20® to Help Protect Infants and Children Against Pneumococcal Disease

NEW YORK, March 13, 2024 Pfizer Inc. (NYSE: PFE) today announced that the European Commission (EC) has granted marketing authorization for the company’s 20-valent pneumococcal conjugate vaccine, marketed in the European Union under the brand name PREVENAR 20®, for active immunization for the prevention of invasive disease, pneumonia and acute otitis media caused by Streptococcus pneumoniae in infants, children and adolescents from 6 weeks to less than 18 years of age.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.